Shanghai Allist Pharmaceuticals Hits Day High with 3.83% Surge

Shanghai Allist Pharmaceuticals Co., Ltd. has shown significant activity today, with the stock rising by 3.83% as of March 10, 2026. The stock reached an intraday high of CNY 98.50, reflecting strong performance in the pharmaceuticals and biotechnology sector. Over the past week, Shanghai Allist has outperformed the China Shanghai Composite, gaining 8.48% compared to the index's marginal increase of 0.01%. Year-to-date, however, the stock has seen a decline of 6.26%, contrasting with the composite's gain of 3.89%. In terms of financial health, the company reported a robust operating cash flow of CNY 2,163.79 million, alongside a net profit of CNY 1,187.76 million, which has grown by 59.72%. The return on equity stands at an impressive 29.94%, indicating strong profitability. With a market capitalization of CNY 43,056 million, Shanghai Allist continues to maintain a solid position within its industry, showcasing resilience and growth potential.